UNI HEALTH News

China Post Securities released a research report on April 28 stating that it gave Guilin Sanjin (002275.SZ) a purchase rating. The main reasons for the rating include: 1) the performance was in line with expectations, and the first quarter was under short

Zhitong FinanceApr 28 16:03

Tianfeng Securities released a research report on April 28 stating that it gave Neusoft Group (600718.SH) a holding rating. The main reasons for the rating include: 1) comments: the company's performance turned losses into profits, and growth potential be

Zhitong FinanceApr 28 10:33

Pacific released a research report on April 24 stating that Baiya shares (003006.SZ) were given a purchase rating. The main reasons for the rating include: 1) the structural drive profit of major health products such as probiotics; 2) high marketing inves

Zhitong FinanceApr 24 09:50

Guojin Securities released a research report on April 22 stating that it gave Kangenbei (600572.SH) an increase in its holdings. The main reasons for the rating include: 1) product structure optimization, healthy growth in the core business of Traditional

Zhitong FinanceApr 22 09:16

Research Report Nuggets | Dongwu Securities: Yaben Chemical actively explores the pharmaceutical+health sector and maintains a “buy” rating

Gelonghui FinanceJul 19, 2023 15:42

Research Report Nuggets | Dongwu Securities: Actively exploring the pharmaceutical+health sector, optimistic about the growth potential of Yaben Chemical, giving it the first “buy” rating

Gelonghui FinanceJul 7, 2023 17:25

Morgan Stanley raised the target price of Jintian Pharmaceutical to 4.5 yuan

摩根士丹利Sep 22, 2014 15:15

Morgan Stanley maintains the target price of 4.5 yuan for Jintian Pharmaceutical Group to increase its holding rating.

Sep 18, 2014 11:43

Research report of Jintian Medicine (2211.HK)

國泰君安國際Jul 21, 2014 00:00

Jintian Medicine (2211.HK)

時富證券Dec 3, 2013 00:00

IPO report: Jintian Pharmaceutical Group Co., Ltd. (2211.HK)

羣益證券(香港)Dec 3, 2013 00:00